| Before matchinga | After matchinga | ||||
---|---|---|---|---|---|---|
 | HR | (95% CI) | P-value | HR | (95% CI) | P-value |
MACCE | 1.258 | 1.088–1.454 | 0.002 | 1.261 | 1.039–1.531 | 0.019 |
 MACE | 1.285 | 1.101–1.499 | 0.001 | 1.204 | 0.979–1.480 | 0.078 |
  All-cause mortality | 1.334 | 1.140–1.562 | <0.001 | 1.301 | 1.053–1.607 | 0.015 |
  Non-fatal acute myocardial infarction | 0.994 | 0.581–1.701 | 0.982 | 0.589 | 0.264–1.314 | 0.196 |
  Target vessel revascularization | 0.612 | 0.272–1.378 | 0.236 | 0.424 | 0.144–1.246 | 0.119 |
   Percutaneous intervention | 0.525 | 0.216–1.275 | 0.154 | 0.319 | 0.094–1.077 | 0.066 |
   Coronary artery bypass graftb | 1.554 | 0.204–1.859 | 0.671 | – | – | – |
 Non-fatal stroke | 1.134 | 0.856–1.501 | 0.382 | 1.326 | 0.923–1.904 | 0.127 |
  Non-fatal hemorrhagic stroke | 0.551 | 0.204–1.492 | 0.241 | 0.556 | 0.154–2.010 | 0.371 |
  Non-fatal ischemic stroke | 1.241 | 0.931–1.654 | 0.141 | 1.492 | 1.027–2.168 | 0.036 |